Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daphnetin Capsule in Vascular Cognitive Impairment Without Dementia
NCT06507488Recruiting
- Sponsor
- Shenyang First People's Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in vascular cognitive impairment (VCI) comparing Daphnetin with Placebo (2 arms). Primary endpoint: Vascular Dementia Assessment Scale-cognitive subscale at 6 months. Started Jul 2025; status: recruiting.
02
Drugs
daphnetin
03
Conditions
vascular cognitive impairment (VCI)
Beyond the preview
Go deeper on NCT06507488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06507488.